Building the Future of Implant Dentistry Through an Integrated Dental Technology Ecosystem

An American Dental Technology & MedTech Platform

American Implants Group (AIG) is building a vertically integrated U.S.-based dental technology platform connecting medical-device manufacturing, advanced implant and prosthetic technologies, digital and AI-enabled workflows, clinician education, technology-enabled patient acquisition, clinical validation, and national and international distribution.

AIG’s strategy is designed to connect innovation, manufacturing, technology, clinicians, and patients through a scalable ecosystem that can accelerate product adoption, expand patient access, and create multiple potential recurring revenue streams.

Innovating. Manufacturing. Educating. Connecting Clinicians and Patients. Scaling Technology.

AIG American Implants Group Video Message for Dental Professionals & Organizations Path to Ownership

Building the Future of Implant Dentistry Through an Integrated Dental Technology Ecosystem

An American Dental Technology & MedTech Platform

Innovating. Manufacturing. Educating. Connecting Clinicians and Patients. Scaling Technology.

A multibillion-dollar implant market with a trillion-dollar untreated clinical opportunity.

Invest in a New Paradigm Shift in Implant Dentistry

American Implants Group is building an integrated American implant dentistry platform designed to make implant treatment more profitable for doctors, more scalable for DSOs, and more affordable for patients.

The global dental implant product market is estimated at approximately $5.56 billion in 2025 and projected to reach approximately $11.02 billion by 2033. In the United States, the dental implant market was estimated at approximately $1.54 billion in 2024 and is projected to reach approximately $3.22 billion by 2033.

KPI cards:

THE PRODUCT MARKET SITS INSIDE A MUCH LARGER CLINICAL OPPORTUNITY

The implant product market represents only one layer of the economic opportunity. The broader ecosystem includes prosthetic components, laboratory services, regenerative materials, digital workflows, professional education, distribution, clinical support, and patient treatment.

Approximately 178 million Americans are estimated to be missing at least one tooth, and approximately 40 million are completely edentulous. Worldwide, oral diseases affect approximately 3.5 billion people, while severe periodontal diseases affect more than 1 billion cases.

WHY AIG EXISTS

Our objective is not simply to sell dental implants. AIG is building a technology-driven ecosystem designed to improve how implant dentistry is developed, manufactured, taught, adopted, delivered, and scaled—while connecting clinicians with the patients who need treatment.

A VERTICALLY INTEGRATED AMERICAN DENTAL TECHNOLOGY PLATFORM

AIG is pursuing a diversified strategy that may include:

Advancing the proposed acquisition of an established U.S. dental implant manufacturer
Modernizing and digitally integrating U.S. medical-device manufacturing
Developing and commercializing advanced implant and prosthetic technologies
Expanding intellectual property, product development, and regulatory capabilities
Building the AIG Implant Training Institute
Accelerating clinician education and technology adoption
Developing technology-enabled patient acquisition and engagement capabilities
Building relationships with dentists, specialists, DSOs, laboratories, and healthcare organizations
Expanding U.S. and international distribution
Evaluating complementary technology acquisitions, licensing opportunities, strategic partnerships, and joint ventures

AIG is currently advancing a proposed acquisition that management believes could provide a foundational U.S. manufacturing platform for the Company’s broader dental technology strategy. The transaction has not yet closed and remains subject to successful completion.

SIMPLIFYING AND RATIONALIZING IMPLANT DENTISTRY

AIG’s defining clinical advantage is its commitment to simplifying and rationalizing implant dentistry.

Our leadership’s experience in clinical care, implant education, treatment planning, surgical and restorative workflows, and practice operations informs a system designed to be:

Easier to learn
More efficient to deliver
More predictable to restore
Less inventory-intensive
More scalable across general practices and DSOs
More affordable and accessible for patients

We believe simplification can support broader clinician adoption without compromising quality, science, or clinical judgment.

THE OPPORTUNITY

Implant Dentistry Is Entering a New Era

The future of implant dentistry extends far beyond manufacturing implant components.

It encompasses:

Digital treatment planning
Artificial intelligence
Advanced biomaterials
Simplified implant systems
Specialized implant centers
Geriatric oral healthcare
Professional education
Digital workflows
Strategic partnerships
Long-term patient care

American Implants Group is being developed to participate across this entire ecosystem.

WHY NOW?

The need for advanced implant dentistry has never been greater.

3.5 Billion+ people affected by oral diseases worldwide
2.5 Billion people affected by untreated dental caries
1 Billion people affected by severe periodontal disease
350 Million people affected by complete tooth loss
2.1 Billion people projected to be age 60 or older by 2050
426 Million people projected to be age 80 or older by 2050

AIG Integrated Ecosystem

One Integrated Platform Across the Implant Value Chain

AIG is designed to connect activities that are traditionally fragmented across the dental implant industry. Each capability supports the others, creating a platform that can accelerate innovation, clinician adoption, patient treatment, and recurring demand.

Ecosystem components

U.S. Medical-Device Manufacturing — Advanced domestic manufacturing, quality systems, automation, product development, supply-chain resilience, and scalable production.
Implant & Prosthetic Technology — Simplified implant systems, prosthetic components, instrumentation, biomaterials, and clinician-centered product innovation.
Digital Dentistry & AI — Digital treatment planning, workflow automation, clinical decision support, data analytics, patient engagement, and AI-enabled capabilities.
AIG Implant Training Institute — Hands-on education, certification, mentorship, digital learning, and clinician adoption of advanced implant technologies.
Technology-Enabled Patient Acquisition — Digital patient education, lead generation, engagement, communication, provider connectivity, and technologies designed to expand access to implant treatment.
Clinical Validation & Adoption Network — Clinical environments supporting technology evaluation, clinician feedback, workflow development, education, outcomes tracking, and real-world commercialization.
National & International Distribution — Dentists, specialists, DSOs, laboratories, universities, healthcare organizations, strategic partners, and international distributors.

Multiple Potential Revenue Streams Across One Integrated Platform

Implant systems and prosthetic components
Abutments, instruments, surgical kits, and biomaterials
Professional education, certification, and mentorship
Digital and laboratory workflow support
AI-enabled operational and educational services
Licensing and distribution
Joint ventures and strategic partnerships
Specialized implant centers
Geriatric and mobile implant programs
Technology and complementary-business acquisitions

AIG’s diversified model is designed to provide investors with exposure to several segments of the implant value chain rather than relying upon a single product or business line.

Strategic Acquisition Opportunities

AIG was established to evaluate, acquire, partner with, and expand established U.S. dental implant manufacturers and complementary dental technology businesses.

Potential targets may offer:

Established product platforms
U.S. manufacturing capabilities
Intellectual property and technical expertise
Historical clinician relationships
Regulatory and quality-management infrastructure
Opportunities for modernization and broader distribution
Strategic compatibility with AIG’s education and clinical ecosystem

The identity of specific acquisition targets, transaction terms, and financial information may be disclosed only to qualified prospective investors and lending institutions through appropriate confidential diligence materials.

SIMPLIFYING IMPLANT DENTISTRY

Smarter Engineering. Simpler Workflows.

Our philosophy is straightforward:

Implant dentistry should become simpler—not more complicated.

Management believes that well-designed systems, coordinated workflows, education, and thoughtful engineering may support more consistent treatment experiences, improved patient understanding, and greater practice efficiency.

Areas of focus include:

Simplified implant systems
Streamlined prosthetics
Digital workflows
Guided surgery
Standardized education
Artificial intelligence
Digital treatment planning

AMERICAN IMPLANT TRAINING INSTITUTE

Education Drives Innovation

The American Implant Training Institute is planned to provide practical education for dentists and clinical teams through:

Hands-on education
Digital dentistry
Guided surgery
Full-arch treatment
Immediate implant protocols
Prosthetic education
Team training
International programs
University collaborations

DIGITAL DENTISTRY & AI

Digital technology is reshaping implant dentistry.

AIG intends to evaluate and support innovations involving:

CBCT integration
Intraoral scanning
CAD/CAM
Guided surgery
Artificial intelligence
Robotics
Digital workflows
Patient communication technologies

Digital case management
AI-assisted workflow support
Treatment planning and clinical decision support
Patient acquisition and lead management
Provider-patient connectivity
Treatment education
Data analytics
Manufacturing automation
Inventory forecasting
Clinician education technology

Do not describe planned technology as already operational or proprietary unless that claim is documented.

AMERICAN MANUFACTURING

AIG is advancing the proposed acquisition of an established U.S. dental implant manufacturer as a foundational component of its broader dental technology strategy.

Upon successful completion of the proposed acquisition, AIG intends to invest substantially in modernization, advanced manufacturing, digital infrastructure, quality systems, product development, automation, and scalable U.S.-based production.

The objective is to develop a modern, digitally integrated medical-device manufacturing platform capable of supporting AIG’s broader technology ecosystem.

PRACTICE PARTNERSHIP PROGRAM

Existing Dental Practices

AIG is actively seeking partnerships with:

Potential collaborations may include education, technology, strategic relationships, practice development, joint ventures, management relationships, or acquisitions where appropriate.

DSO PARTNERSHIP PROGRAM

DSOs represent one of the largest opportunities for expanding implant dentistry.

Potential areas of collaboration include:

Implant education
Clinical protocols
Digital workflows
Practice development
Specialized implant centers
Geriatric dentistry
Technology integration

STRATEGIC PARTNERSHIPS

AIG welcomes discussions with:

Manufacturers
Universities
Technology companies
AI developers
Laboratories
International distributors
Senior-care organizations
Strategic advisors

Total Addressable Market — TAM

United States TAM

Approximately 178 million Americans are missing at least one tooth, and tens of millions are fully edentulous. At an estimated treatment value of $3,100 to $5,800 per single implant case, the theoretical U.S. single-tooth implant treatment opportunity exceeds $550 billion to over $1 trillion.

For edentulous and near-edentulous patients requiring implant overdentures, fixed full-arch treatment, or advanced implant-supported prosthetics, the clinical opportunity is even larger because treatment often involves multiple implants, abutments, prosthetics, extractions, grafting, laboratory services, and ongoing maintenance.

Global TAM

Globally, oral diseases affect approximately 3.5 billion people, and severe periodontal disease affects more than 1 billion people worldwide. Published global burden data projects that by 2050, more than 1.5 billion people may suffer from severe periodontitis and more than 660 million people may be edentulous.

Using only the projected global edentulous population, the potential full-arch and implant-supported prosthetic treatment opportunity represents a theoretical global clinical TAM measured in the trillions of dollars.

Market Opportunity

Aging population
Rising edentulism and partial tooth loss
Demand for affordable implant solutions
Need for simplified implant systems
Growth of training-based product adoption
International opportunity, especially Mexico and China

Proposed Strategic Acquisition

American Implants Group is advancing a proposed acquisition of an established U.S. dental implant manufacturer with a long operating history and existing manufacturing capabilities.

The proposed transaction has not closed and remains subject to due diligence, financing, definitive documentation, regulatory and other applicable requirements, and customary closing conditions.

🏛️

Founded legacy American dental implant company

🦷

Existing product platform

🏭

American-made positioning

🚀

Historical clinical user base

🎓

Manufacturing know-how

📈

Opportunity for modernization

🌎

Potential U.S., Mexico, China, and international expansion

🏆

Training-driven product adoption

The AIG Growth Strategy

AIG’s growth strategy focuses on innovation, education, strategic expansion, and industry partnerships. By combining advanced implant solutions with dentist-focused training and scalable distribution, AIG aims to strengthen its U.S. market presence and support future global expansion.

🏥

The AIG Growth Strategy

Upon completion of a proposed strategic acquisition, AIG intends to strengthen and modernize the acquired implant platform while expanding product development, education, distribution, brand recognition, and market presence.

🎓

Launch the AIG Implant Training Institute

Create a premier education and certification platform focused on advanced implantology techniques and clinical excellence.

🦷

Educate Dentists in Immediate Implant Placement and Loading

Provide hands-on training programs that help dentists adopt modern immediate-load implant procedures with confidence.

🏥

Expand Distribution in the United States

Increase nationwide accessibility through strategic distributor relationships, sales expansion, and market penetration initiatives.

🌎

Develop International Strategic Partnerships

Build alliances with global dental organizations, distributors, and educators to support international growth opportunities.

🤝

Create a Dentist-Shareholder Ecosystem

Develop a collaborative model that aligns dentists, educators, and investors through shared participation and long-term value creation.

THE AIG GROWTH FLYWHEEL

Acquire & Develop Technology
Modernize U.S. Manufacturing
Develop Advanced Products
Train Clinicians
Accelerate Technology Adoption
Increase Product Utilization
Generate Data & Clinical Feedback
Improve Products and Workflows
Expand Distribution
Reinvest in Technology & Innovation

Why American Implants Group Is Positioned Differently

American Implants Group is not being built as a traditional implant company selling components alone. AIG is creating an integrated implant ecosystem combining:

Clinician-led implant technology and workflow development
U.S.-based manufacturing strategy
Simplified surgical and restorative implant workflows
Training integrated with clinical product adoption
Digital dentistry and artificial intelligence integration
Clinical validation and practitioner feedback network
Laboratory and prosthetic support
National and international distribution strategy
Focus on geriatric dentistry and underserved patient populations
Multiple complementary and potentially scalable revenue channels

This creates an opportunity to participate across a larger portion of the implant value chain — from manufacturing and education to clinical support, laboratory integration, and patient treatment delivery.

The Implant Training Institute: Education Is the Engine of Adoption

The AIG Implant Training Institute is intended to help dentists and clinical teams confidently incorporate implant dentistry into their practices through practical education, simplified protocols, mentorship, and technology-enabled learning.

Programs may include:

Hands-on surgical and prosthetic education
Full-arch rehabilitation
Guided surgery and digital treatment planning
Implant-supported treatment for older adults
Restorative workflows and long-term maintenance
Team education and practice implementation
University and international collaborations
AI-supported learning and case-based education

MULTIPLE COMPLEMENTARY REVENUE STREAMS

AIG is being designed around complementary revenue channels that may include implant systems, prosthetic components, surgical instruments, regenerative products, professional education, licensing, distribution, strategic partnerships, laboratory support, and digital workflows.

This platform approach may increase customer lifetime value, diversify revenue, and reduce dependence on a single product category.

Artificial Intelligence as an Enabling Capability Across AIG

AI strengthens the AIG ecosystem; it does not replace the core implant-platform investment thesis.

AIG intends to evaluate and integrate artificial intelligence across its manufacturing, education, clinical, operational, and patient-access activities. The objective is to use AI where it can create measurable value by improving efficiency, predictability, clinician support, scalability, and patient access.

Potential AI capabilities may be developed internally or introduced through licensing, acquisitions, and strategic technology partnerships.

AI application categories

Product development

U.S. manufacturing

Implant Training Institute

Digital clinical workflows

Patient access and communication

Practice and DSO operations

Important disclaimer

Potential AI and digital applications are forward-looking and may be subject to development, validation, licensing, privacy, cybersecurity, clinical oversight, and applicable regulatory requirements.

The AIG Data, Adoption, and Revenue Flywheel

As AIG’s manufacturing, education, and clinical activities expand, the platform may generate increasingly valuable operational and clinical information. Subject to appropriate privacy protections and regulatory requirements, these insights can support better training, product development, manufacturing efficiency, clinical workflows, and patient engagement.

More activity can create better information. Better information can improve workflows. Better workflows can accelerate adoption and strengthen long-term enterprise value.

Why Investors Should Pay Attention

AIG is designed for investors who understand that dental implants are not a short-term trend. Implant dentistry is one of the most important growth areas in modern dentistry, and ownership in an implant platform may provide exposure to manufacturing, education, distribution, and clinical adoption.

Key points:

WHY INVESTORS AND INDUSTRY PARTNERS SHOULD PAY ATTENTION

American Implants Group (AIG) is building an integrated dental implant platform that combines manufacturing, education, innovation, strategic acquisitions, and industry partnerships. As demand for dental implants continues to grow worldwide, AIG aims to create long-term value by supporting dentists, laboratories, DSOs, distributors, institutions, and international markets.

Why AIG stands out:

Growing demand driven by aging populations and increasing tooth replacement needs
Focus on high-quality, American-made implant systems and innovation
Clinician-led product development based on real-world clinical experience
Education and training designed to accelerate product adoption
Multiple potential recurring revenue opportunities
Diversified strategy through acquisitions, partnerships, licensing, and expansion
Opportunities for dentists, strategic partners, and investors to help expand into new markets

AIG’s objective is to build a scalable, diversified dental technology company that improves the accessibility, predictability, and efficiency of implant dentistry while creating long-term enterprise value for its stakeholders.

Analyze clinician feedback and product-performance information
Identify opportunities for simplified implant and restorative workflows
Support research, product development, and protocol improvement
Laboratory and prosthetic support
Scalable treatment workflows
Patient-access strategies for older adults and edentulous patients
Affordable implant solutions designed to expand case acceptance

Investor Information

American Implants Group is engaging with prospective accredited investors and strategic partners. Any offering of securities will be made only in accordance with applicable securities laws and pursuant to applicable offering and subscription documents.

IMPORTANT: Final securities-related language should be reviewed and approved by AIG’s securities counsel before publication or use in investor solicitation.

INVESTOR RELATIONS

American Implants Group is building a diversified dental technology platform.

Qualified investors may request confidential information through our secure investor process.

Contact us

AIG is designed for investors who understand that dental implants are not a short-term trend.

AIG INVESTMENT THESIS

AIG American Implants Group LLC was established to acquire, invest in, modernize, and expand established American dental implant and dental-technology businesses while building a broader integrated platform encompassing manufacturing, education, digital dentistry, clinical adoption, artificial intelligence, and distribution.

The Company’s vision is to participate in a paradigm shift within implant dentistry by helping create a simplified, streamlined, clinically predictable, and affordable implant system that benefits both dental professionals and the patients they serve.

For decades, the global dental implant market has been dominated by a relatively small number of large international manufacturers. AIG believes there is a significant opportunity for a well-capitalized American implant company to expand its market position through innovation, education, distribution, manufacturing excellence, and strong partnerships with dentists, specialists, laboratories, educational institutions, and healthcare organizations.

The Company’s long-term objective is to transform its acquired implant platform into one of the leading dental implant organizations in the world while maintaining a commitment to American manufacturing, product quality, clinical excellence, affordability, and professional education.

AIG believes that the future of implant dentistry requires solutions that are:

Simpler to learn and use
More predictable clinically
More efficient for doctors and their teams
More affordable for patients
Supported by high-quality education and training
Manufactured to the highest quality standards

The Company intends to support the continued evolution of implant dentistry through strategic investments in manufacturing, research, education, digital technologies, clinical training, distribution, and practice-development initiatives.

Many prospective investors are expected to include dentists, specialists, dental laboratories, distributors, dental organizations, educators, and other healthcare professionals who share an interest in advancing implant dentistry through improved clinical predictability, greater efficiency, enhanced patient access, and sustainable practice profitability.

The Company believes that aligning the interests of manufacturers, clinicians, educators, distributors, and patients creates a powerful opportunity to accelerate innovation while supporting long-term growth and value creation.